Viewing Study NCT00335205

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:15 AM
Ignite Modification Date: 2025-12-31 @ 9:41 PM
Study NCT ID: NCT00335205
Status: UNKNOWN
Last Update Posted: 2006-06-09
First Post: 2006-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
Sponsor: Sheba Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bipolar Disorder View
None Major Depressive Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ropinirole View
None dopamine View
None D2 View
None depression View
None bipolar View